HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 45 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -47.6% | 17,890 | +326.0% | 0.00% | – |
| Q3 2018 | $21,000 | -65.6% | 4,200 | -77.7% | 0.00% | – |
| Q2 2018 | $61,000 | – | 18,800 | +9300.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 200 | -90.5% | 0.00% | – |
| Q4 2017 | $4,000 | +100.0% | 2,100 | +75.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 1,200 | +140.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 500 | +400.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | -52.4% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 210 | -99.2% | 0.00% | – |
| Q3 2016 | $57,000 | -6.6% | 25,412 | +13.0% | 0.00% | – |
| Q2 2016 | $61,000 | +408.3% | 22,496 | +399.9% | 0.00% | – |
| Q1 2016 | $12,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 5,790,269 | $3,848,000 | 3.74% |
| PERKINS CAPITAL MANAGEMENT INC | 2,353,153 | $1,564,000 | 1.35% |
| Diametric Capital, LP | 269,822 | $179,000 | 0.15% |
| Nantahala Capital Management | 5,000,000 | $3,323,000 | 0.12% |
| Sio Capital Management, LLC | 300,000 | $199,000 | 0.06% |
| Cowen Prime Services LLC | 100,000 | $66,000 | 0.03% |
| Fondren Management LP | 40,375 | $27,000 | 0.02% |
| Kalos Management, Inc. | 66,900 | $46,000 | 0.02% |
| Alyeska Investment Group, L.P. | 1,387,665 | $922,000 | 0.01% |
| Hayden Royal, LLC | 12,000 | $8,000 | 0.01% |